Results 161 to 170 of about 18,243 (254)
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Global Initiative on AI for Health (GI-AI4H): strategic priorities advancing governance across the United Nations. [PDF]
Muralidharan V +17 more
europepmc +1 more source
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Household Income Diversification and Food Insecurity: A Case Study of Afghanistan. [PDF]
Niazi R +5 more
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Centers for Medicare & Medicaid Services Approval of Cardiac Ablations in Ambulatory Surgery Centers: Challenges and Emerging Models Shaping the Future of Cardiac Electrophysiology. [PDF]
Aryana A, Swarup V.
europepmc +1 more source
Synthesis of the Commission’s management achievements in 2006. COM (2007) 274 final, 20 May 2007 [PDF]
core
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source
Data science and artificial intelligence for maternal, newborn and child health: scoping review and thematic analysis. [PDF]
Akuze J +9 more
europepmc +1 more source
ITMA - IT Integration in mergers and acquisitions [PDF]
Burke, Declan, Kovela, Serhiy
core +1 more source

